Hims & Hers Health (HIMS) News Today → Do you know the 3 golden rules for dividend investing? (From DTI) (Ad) Free HIMS Stock Alerts $23.75 -0.62 (-2.54%) (As of 06/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 15 at 8:40 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Trading Down 0.5%June 15 at 1:48 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) PT Raised to $26.00 at Bank of AmericaJune 14 at 3:48 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Down 2.4% Hims & Hers Health (NYSE:HIMS) Trading Down 2.4%June 13 at 4:00 PM | seekingalpha.comHims & Hers: Compounded Semaglutide Boost Unlikely To Last - Moderate Risks AheadJune 13 at 1:27 AM | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Down 0.5% Following Insider SellingJune 12 at 4:50 PM | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Up 5.8%Hims & Hers Health (NYSE:HIMS) Shares Up 5.8%June 12 at 11:47 AM | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 1-Year High at $23.49Hims & Hers Health (NYSE:HIMS) Reaches New 12-Month High at $23.49June 12 at 4:18 AM | americanbankingnews.comHims & Hers Health, Inc. (NYSE:HIMS) Director Christopher D. Payne Purchases 110,000 SharesJune 11, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock Price Down 0.5% Following Insider SellingHims & Hers Health (NYSE:HIMS) Stock Price Down 0.5% After Insider SellingJune 11, 2024 | marketbeat.comVerition Fund Management LLC Raises Position in Hims & Hers Health, Inc. (NYSE:HIMS)Verition Fund Management LLC raised its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 30.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 798,660 shares of the compaJune 11, 2024 | americanbankingnews.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells 98,635 Shares of StockJune 11, 2024 | insidertrades.comInsider Buying: Hims & Hers Health, Inc. (NYSE:HIMS) Director Acquires 110,000 Shares of StockJune 10, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 98,635 SharesHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 98,635 shares of the company's stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $21.42, for a total value of $2,112,761.70. Following the transaction, the chief financial officer now directly owns 146,839 shares of the company's stock, valued at $3,145,291.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.June 10, 2024 | seekingalpha.comHims & Hers: Ready For TakeoffJune 10, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Up 5.7%Hims & Hers Health (NYSE:HIMS) Stock Price Up 5.7%June 10, 2024 | seekingalpha.comHims & Hers: Beware Of Chasing Weight Loss Drugs FOMOJune 10, 2024 | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & HersOne of the market's most closely watched economic reports made a sudden turn last week. The employment situation report (NFP) showed that the U.S. economy is still resiliently adding jobs despite seeing some contradicting indicators placing a ceiling on its growth.June 10, 2024 | marketbeat.com3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers (HIMS)These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are realJune 10, 2024 | seekingalpha.comBeyond The Marketing Machine: Why Hims & Hers Stock Might Be VulnerableJune 9, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Shares Down 1.9% June 8, 2024 | marketbeat.comMarketBeat Week in Review – 6/3 - 6/7 (HIMS)Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next weekJune 8, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Trading Down 1.7% on Insider SellingJune 7, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Sets New 52-Week High at $21.55June 7, 2024 | americanbankingnews.comHims & Hers Health Target of Unusually Large Options Trading (NYSE:HIMS)June 6, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading Down 1.7% After Insider SellingHims & Hers Health (NYSE:HIMS) Trading Down 1.7% on Insider SellingJune 6, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) COO Melissa Baird Sells 17,625 SharesJune 6, 2024 | insidertrades.comHims & Hers Health, Inc. (NYSE:HIMS) CEO Andrew Dudum Sells 188,888 SharesJune 6, 2024 | americanbankingnews.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $2,664,656.85 in StockJune 5, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) COO Sells 17,625 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) COO Melissa Baird sold 17,625 shares of the firm's stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $20.42, for a total transaction of $359,902.50. Following the sale, the chief operating officer now directly owns 541,432 shares of the company's stock, valued at approximately $11,056,041.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.June 5, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Up 3.1%Hims & Hers Health (NYSE:HIMS) Trading 3.1% HigherJune 5, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 12-Month High at $21.55Hims & Hers Health (NYSE:HIMS) Hits New 1-Year High at $21.55June 5, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Shares Purchased by Dimensional Fund Advisors LPDimensional Fund Advisors LP increased its position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 9.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,147,927 shares of the company's stockJune 5, 2024 | americanbankingnews.comHims & Hers Health (NYSE:HIMS) Stock Price Down 1.2% Following Insider SellingJune 4, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Shares Down 1.2% on Insider SellingHims & Hers Health (NYSE:HIMS) Stock Price Down 1.2% Following Insider SellingJune 3, 2024 | marketbeat.comInsider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 129,667 Shares of StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 129,667 shares of the company's stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $20.55, for a total transaction of $2,664,656.85. Following the transaction, the insider now owns 156,855 shares in the company, valued at approximately $3,223,370.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.June 3, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Trading 6.5% Higher Following Analyst UpgradeHims & Hers Health (NYSE:HIMS) Trading Up 6.5% Following Analyst UpgradeJune 3, 2024 | marketbeat.comHims & Hers Health Soars on Generic GLP-1 Rollout PlansHim & Hers Health Inc. NYSE: HIMS provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments for erectile dysfunction (ED) through brand and generic versions of Pfizer Inc. NYSE: PFE Viagra (Sildenafil) and Eli Lilly & Co. NYSE: LLY Cialis (Tadalafil).June 3, 2024 | marketbeat.comHims & Hers Health Soars on Generic GLP-1 Rollout Plans Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatmentsJune 1, 2024 | fool.comHims & Hers Health Stock Soared This Week: Here's WhyMay 31, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Stock Price Down 2.7%Hims & Hers Health (NYSE:HIMS) Stock Price Down 2.7%May 31, 2024 | insidertrades.comSoleil Boughton Sells 2,502 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) StockMay 31, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Short Interest Up 20.3% in MayHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 22,130,000 shares, a growth of 20.3% from the April 30th total of 18,390,000 shares. Currently, 14.7% of the company's stock are sold short. Based on an average daily trading volume, of 8,300,000 shares, the short-interest ratio is presently 2.7 days.May 30, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Reaches New 52-Week High at $21.16Hims & Hers Health (NYSE:HIMS) Sets New 1-Year High at $21.16May 30, 2024 | marketbeat.comCall Option Volumes Spiked For These 3 StocksAs the saying goes, always follow the money. This time, investors can follow the proverbial big players through an options activity screener, spotting unusual trends in how markets are betting.May 30, 2024 | marketbeat.comCall Option Volumes Spiked For These 3 Stocks (HIMS)Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decisionMay 30, 2024 | marketbeat.comTrexquant Investment LP Purchases New Shares in Hims & Hers Health, Inc. (NYSE:HIMS)Trexquant Investment LP acquired a new position in Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 124,469 shares of the company's stock, valued at approxMay 30, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) have been given an average rating of "Moderate Buy" by the fifteen brokerages that are covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold recommendation and eight have issued a buyMay 29, 2024 | marketbeat.comHims & Hers Health, Inc. (NYSE:HIMS) Insider Sells $43,359.66 in StockHims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Soleil Boughton sold 2,502 shares of the firm's stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of $17.33, for a total value of $43,359.66. Following the transaction, the insider now directly owns 156,855 shares of the company's stock, valued at $2,718,297.15. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 29, 2024 | benzinga.comSmart Money Is Betting Big In HIMS OptionsMay 28, 2024 | marketbeat.comHims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeHims & Hers Health (NYSE:HIMS) Sees Large Volume Increase Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Indicator Is Bullish (Ad)If you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward… >> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo Related Videos HIMS Media Mentions By Week HIMS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HIMS News Sentiment▼0.470.89▲Average Medical News Sentiment HIMS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HIMS Articles This Week▼238▲HIMS Articles Average Week Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TDOC News Today AUNA News Today LFMD News Today AIRS News Today SHLT News Today PTWO News Today TOI News Today CCM News Today ALNY News Today ALGN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:HIMS) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.